Crispr Therapeutics AG (CRSP) Insider Trading
- $79,647,674.22
- $317,867,595.33
- July 16, 2025
- Samarth Kulkarni
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 5, 2017 | CEO | 616 | $16.92 | Sell | $10,422.72 | |
| May 4, 2017 | CEO | 49,384 | $16.30 | Sell | $804,959.20 | |
| April 28, 2017 | Insider | 21,639 | $16.78 | Sell | $363,102.42 | |
| April 27, 2017 | Insider | 5,481 | $16.76 | Sell | $91,861.56 | |
| April 25, 2017 | Insider | 11,615 | $16.78 | Sell | $194,899.70 | |
| April 20, 2017 | Insider | 10,177 | $17.71 | Sell | $180,234.67 | |
| April 20, 2017 | CEO | 50,000 | $17.88 | Sell | $894,000.00 | |
| Oct. 24, 2016 | Director | 66,500 | $14.00 | Buy | $931,000.00 | |
| Oct. 24, 2016 | Major Shareholder | 800,150 | $14.00 | Buy | $11,202,100.00 |
Insiders are both buying and selling Crispr Therapeutics AG stock.
The insider traders at Crispr Therapeutics AG are: Samarth Kulkarni, Rodger Novak, Kurt Von Emster, Bradley J Phd Bolzon, Corp /De/ Celgene, Tyler Dylan-Hyde, Pablo J Cagnoni, Thomas Woiwode, Lawrence Otto Klein, James R Kasinger, Vertex Pharmaceuticals (Europe, Michael John Tomsicek, Julianne Bruno, Simeon George, Naimish Patel, Bradley J. Phd Bolzon, James R. Kasinger, John Greene, Aktiengesellschaft Bayer, Raju Prasad, Tony W Ho, Tony W. Ho, and Versant Venture Capital V, L.P
The most active insider trader at Crispr Therapeutics AG is Samarth Kulkarni with 36 trades.
Kurt Von Emster has sold the most Crispr Therapeutics AG stock with a total value of $68,130,025.01.
Simeon George has bought the most Crispr Therapeutics AG stock with a total value of $103,930,836.72.
The most recent insider trade for Crispr Therapeutics AG was on July 16, 2025.
The single biggest insider buy for Crispr Therapeutics AG was from Simeon George with a total value of $51,499,918.36 on July 16, 2025.
The single biggest insider sell for Crispr Therapeutics AG was from Kurt Von Emster with a total value of $35,353,500.00 on May 14, 2018.